Table 3 Univariate tests for suspected CVD risk factors and drugs with possible association to CVD
From: Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
Variable | No CVDb | CVDc | Testd | p-value | q-value |
|---|---|---|---|---|---|
Numbera | 71 | 22 | |||
Age (mean) | 61.4 | 71.1 | Mann-W | 0.003 | 0.057 |
Gender = 1(%) | 32 (45.1) | 7 (31.8) | Chisq | 0.393 | 0.885 |
DXR (mean) | 493.4 | 417.9 | Mann-W | 0.121 | 0.436 |
Smoking (%) | 24 (43.6) | 9 (52.9) | Chisq | 0.693 | 0.960 |
BMI (mean) | 26.3 | 24.7 | Mann-W | 0.282 | 0.726 |
Cardiac (%) | 14 (20.0) | 5 (23.8) | Chisq | 0.944 | 1.000 |
CVD (%) | 21 (30.0) | 8 (38.1) | Chisq | 0.666 | 0.960 |
HT (%) | 21 (30.0) | 11 (52.4) | Chisq | 0.105 | 0.436 |
DM(%) | 9 (12.9) | 4 (19.0) | Fisher | 0.488 | 0.960 |
CRP (mean) | 40.2 (70.9) | 39.1 (53.6) | Mann-W | 0.955 | 1.000 |
GFR (%) | 11 (16.2) | 5 (23.8) | Chisq | 0.638 | 0.960 |
AB (%) | 26 (36.6) | 6 (27.3) | Chisq | 0.583 | 0.960 |
IPIhigh (%) | 22 (31.9) | 7 (31.8) | Chisq | 1.000 | 1.000 |
Metformin = 1(%) | 7 (10.0) | 2 (9.5) | Fisher | 1.000 | 1.000 |
B-block (%) | 10 (14.3) | 6 (28.6) | Chisq | 0.237 | 0.712 |
ACE/ARB (%) | 14 (20.0) | 10 (47.6) | Chisq | 0.025 | 0.228 |
B-block/ACE-ARB (%) | 19 (27.1) | 11 (52.4) | Chisq | 0.058 | 0.350 |
Statin (%) | 16 (22.9) | 6 (28.6) | Chisq | 0.806 | 1.000 |